| Name | JT002 |
|---|
| Description | JT002 is an orally active inhibitor of the NLRP3 inflammasome. JT002 reduces NLRP3-dependent proinflammatory cytokine (such as IL-1β, IL-1α, IL-18) production and pyroptosis. JT002 blocks NLRP3 inflammasome complex formation. JT002 reduces airway hyperresponsiveness and airway neutrophilia in mice[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C20H24N4O5S |
|---|---|
| Molecular Weight | 432.49 |